Abstract
The aim of this study was to evaluate the carcinogenic risks associated with radiation in mass mammographic screening. Assessment was in terms of breast cancer mortality and years of life for a hypothetical cohort of 100 000 women. Data were obtained on incidence, mortality and life expectancy for the female population of Stockholm. With a screening interval of 18 months at ages 40–49 years, a total absorbed dose to the breast of 13 mGy per invited woman; and an annual breast cancer reduction of 25% per year 7 years from screening start, the net number of years gained was at least 2800. However, using the highest absorbed dose reported in routine mammographic screening in Sweden (≈3 mGy per view), and the highest reported radiation risk in the literature, a programme entailing annual screening with 2 views would require at least a 20% annual reduction in breast cancer mortality to give a net benefit in both the number of years of life gained and number of breast cancer deaths avoided. This observation supports the conclusion that exposures with low absorbed dose are essential when performing mass screening with mammography among young women. © 2000 Cancer Research Campaign
Keywords: mammographic screening, radiation risk, life years
Full Text
The Full Text of this article is available as a PDF (113.6 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Andersson I., Janzon L. Reduced breast cancer mortality in women under age 50: updated results from the Malmö Mammographic Screening Program. J Natl Cancer Inst Monogr. 1997;(22):63–67. doi: 10.1093/jncimono/1997.22.63. [DOI] [PubMed] [Google Scholar]
- Bjurstam N., Björneld L., Duffy S. W., Smith T. C., Cahlin E., Eriksson O., Hafström L. O., Lingaas H., Mattsson J., Persson S. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization. Cancer. 1997 Dec 1;80(11):2091–2099. [PubMed] [Google Scholar]
- Boice J. D., Jr, Preston D., Davis F. G., Monson R. R. Frequent chest X-ray fluoroscopy and breast cancer incidence among tuberculosis patients in Massachusetts. Radiat Res. 1991 Feb;125(2):214–222. [PubMed] [Google Scholar]
- Fletcher S. W., Black W., Harris R., Rimer B. K., Shapiro S. Report of the International Workshop on Screening for Breast Cancer. J Natl Cancer Inst. 1993 Oct 20;85(20):1644–1656. doi: 10.1093/jnci/85.20.1644. [DOI] [PubMed] [Google Scholar]
- Land C. E. Estimating cancer risks from low doses of ionizing radiation. Science. 1980 Sep 12;209(4462):1197–1203. doi: 10.1126/science.7403879. [DOI] [PubMed] [Google Scholar]
- Mattsson A., Rudén B. I., Palmgren J., Rutqvist L. E. Dose- and time-response for breast cancer risk after radiation therapy for benign breast disease. Br J Cancer. 1995 Oct;72(4):1054–1061. doi: 10.1038/bjc.1995.461. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nyström L., Rutqvist L. E., Wall S., Lindgren A., Lindqvist M., Rydén S., Andersson I., Bjurstam N., Fagerberg G., Frisell J. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet. 1993 Apr 17;341(8851):973–978. doi: 10.1016/0140-6736(93)91067-v. [DOI] [PubMed] [Google Scholar]
- Shore R. E., Hildreth N., Woodard E., Dvoretsky P., Hempelmann L., Pasternack B. Breast cancer among women given X-ray therapy for acute postpartum mastitis. J Natl Cancer Inst. 1986 Sep;77(3):689–696. doi: 10.1093/jnci/77.3.689. [DOI] [PubMed] [Google Scholar]
- Tokunaga M., Land C. E., Tokuoka S., Nishimori I., Soda M., Akiba S. Incidence of female breast cancer among atomic bomb survivors, 1950-1985. Radiat Res. 1994 May;138(2):209–223. [PubMed] [Google Scholar]